Inovio Pharmaceuticals Inc (INO): Next-Year EPS Estimate 51.07%
As of 2026-06-04, Inovio Pharmaceuticals Inc (INO) has a next-year EPS growth estimate of 51.07%.
INO was first flagged by our screen on 2026-06-01, when analyst consensus for its next-year EPS growth was revised from 46.12% to 51.07%. Current-year growth is projected at 51.25%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 51.07%
- EPS growth this year
- 51.25%
- EPS next quarter (est)
- -$0.24
- Last price
- $1.16
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 51.07% | 51.25% | -$0.24 | $1.16 |
| 2026-06-03 | 51.07% | 51.25% | -$0.24 | $1.14 |
| 2026-06-02 | 51.07% | 51.25% | -$0.24 | $1.21 |
| 2026-06-01 | 51.07% | 51.25% | -$0.24 | $1.28 |
| 2026-05-31 | 46.12% | 50.80% | -$0.24 | $1.31 |
| 2026-05-28 | 46.12% | 50.80% | -$0.24 | $1.30 |
| 2026-05-27 | 46.12% | 50.80% | -$0.24 | $1.25 |
| 2026-05-26 | 46.12% | 50.80% | -$0.24 | $1.26 |
| 2026-05-25 | 46.12% | 50.80% | -$0.24 | $1.35 |
| 2026-05-24 | 46.12% | 50.80% | -$0.24 | $1.35 |
| 2026-05-21 | 46.79% | 48.37% | -$0.25 | $1.33 |
| 2026-05-20 | 46.79% | 48.37% | -$0.25 | $1.23 |
| 2026-05-19 | 46.79% | 48.37% | -$0.25 | $1.22 |
| 2026-05-18 | 46.79% | 48.37% | -$0.25 | $1.22 |
| 2026-05-17 | 46.79% | 48.37% | -$0.25 | $1.30 |
| 2026-05-14 | 46.73% | 48.40% | -$0.25 | $1.36 |
| 2026-05-13 | 58.12% | 36.69% | -$0.35 | $1.34 |
| 2026-05-12 | 58.12% | 36.69% | -$0.35 | $1.41 |
| 2026-05-11 | 58.12% | 36.69% | -$0.35 | $1.43 |
| 2026-05-10 | 58.12% | 36.69% | -$0.35 | $1.46 |
| 2026-05-07 | 58.12% | 36.69% | -$0.35 | $1.37 |
| 2026-05-06 | 58.12% | 36.69% | -$0.35 | $1.24 |
| 2026-05-05 | 58.12% | 36.69% | -$0.35 | $1.14 |
| 2026-05-04 | 58.12% | 36.69% | -$0.35 | $1.14 |
| 2026-05-03 | 58.12% | 36.69% | -$0.35 | $1.10 |
| 2026-04-30 | 58.12% | 36.69% | -$0.35 | $1.12 |
| 2026-04-29 | 58.12% | 36.69% | -$0.35 | $1.12 |
| 2026-04-28 | 58.12% | 36.69% | -$0.35 | $1.15 |
| 2026-04-27 | 58.12% | 36.69% | -$0.35 | $1.17 |
| 2026-04-26 | 58.12% | 36.69% | -$0.35 | $1.15 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Inovio Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Inovio Pharmaceuticals Inc (INO) has a next-year EPS growth estimate of 51.07%, based on analyst consensus.
When was the latest EPS estimate revision for INO?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 46.12% to 51.07%.
What sector and industry does Inovio Pharmaceuticals Inc belong to?▾
Inovio Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Inovio Pharmaceuticals Inc (INO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports